TopNews

With no medications available for deadly dengue fever and the disease assuming endemic proportions in nations such as India and extending to the US for the first time during the last 40 years.

Now, a multi-million dollar research has been launched at Canada's McMaster University to contain the virus.

Prof Mark Loeb of the Michael G. DeGroote School of Medicine at the university has been granted $10 million by the US National Institutes of Health to carry out an international research on dengue.

Tilaknagar Industries, a maker of Indian Made Foreign Liquor, commenced trading on the National Stock Exchange today.

The shares of the company, which belled the day at Rs 160.10, was trading 3.9% up at Rs 163 during noon trade as against its last closing figure of Rs 156.85 as registered on the BSE.

The company's scrip will be traded under the symbol 'TI'.

The company said that trading at the NSE would perk up the liquidity of the scrip and augment its accessibility.

After a jerky session during morning, the 30-scrip sensitive index (Sensex) of the Bombay Stock Exchange (BSE) remained quiet a little before noon.

The Sensex, which belled the day at 17,911.13, was trading 8.23 points up at 17,917.69 as against its last closure at 17,909.46.

In contrast, the broad-based Nifty remained flat at 5,384.15, up 0.1% as against its last closure at 5,378.75.

The BSE midcap index surged 0.4% the BSE smallcap index grew by 0.77%.

Stock market analyst Anil Maghnani has maintained 'buy' rating on State Bank of India Ltd stock with short term target of Rs 2490.

According to analyst, the investors can buy the stock with stop loss of Rs 2424.

Today, the stock opened at Rs 2440 on the Bombay Stock Exchange (BSE).

Current EPS & P/E ratio stood at 144.37 and 16.96 respectively.

The share price has seen a 52-week high of Rs 2500 and a low of Rs 1599.40 on BSE.

The Cabinet, on July 15, has sanctioned the acquisition of State Bank of Indore by SBI.

Stock market analyst Vijay Bhambwani has maintained 'buy' rating on Sun Pharmaceutical Industries Ltd stock with a target of Rs 1820-1825.

According to analyst, the investors can buy the stock with stop loss of Rs 1680.

Today, the stock opened at Rs 1755 on the Bombay Stock Exchange (BSE).

Current EPS & P/E ratio stood at 65.23 and 26.62 respectively.

The share price has seen a 52-week high of Rs 1846 and a low of Rs 1159 on BSE.

Stock market analyst Mileen Vasudeo has maintained 'hold' rating on Indian Overseas Bank stock to achieve a target between Rs 125-127.

According to analyst, the investors can hold the stock with stop loss of Rs 103.

Today, the stock of the company opened at Rs 110.50 on the Bombay Stock Exchange (BSE).

Current EPS & P/E ratio stood at 8.78 and 12.56 respectively.

The share price has seen a 52-week high of Rs 141 and a low of Rs 79 on BSE.